These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31980625)

  • 21. Control of cyclic oligoadenylate synthesis in a type III CRISPR system.
    Rouillon C; Athukoralage JS; Graham S; Grüschow S; White MF
    Elife; 2018 Jul; 7():. PubMed ID: 29963983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cyclic oligoadenylate synthesis by the
    Nasef M; Muffly MC; Beckman AB; Rowe SJ; Walker FC; Hatoum-Aslan A; Dunkle JA
    RNA; 2019 Aug; 25(8):948-962. PubMed ID: 31076459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
    Niewoehner O; Garcia-Doval C; Rostøl JT; Berk C; Schwede F; Bigler L; Hall J; Marraffini LA; Jinek M
    Nature; 2017 Aug; 548(7669):543-548. PubMed ID: 28722012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of Csm6 ribonuclease by cyclic nucleotide binding: in an emergency, twist to open.
    McQuarrie S; Athukoralage JS; McMahon SA; Graham S; Ackermann K; Bode BE; White MF; Gloster TM
    Nucleic Acids Res; 2023 Oct; 51(19):10590-10605. PubMed ID: 37747760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic oligoadenylate signalling and regulation by ring nucleases during type III CRISPR defence.
    Athukoralage JS; White MF
    RNA; 2021 May; 27(8):855-67. PubMed ID: 33986148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic Tetra-Adenylate (cA
    Charbonneau AA; Eckert DM; Gauvin CC; Lintner NG; Lawrence CM
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate selectivity and catalytic activation of the type III CRISPR ancillary nuclease Can2.
    Jungfer K; Sigg A; Jinek M
    Nucleic Acids Res; 2024 Jan; 52(1):462-473. PubMed ID: 38033326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shoot the Messenger! A New Phage Weapon to Neutralize the Type III CRISPR Immune Response.
    Shilton AK; Marraffini LA
    Mol Cell; 2020 May; 78(4):568-569. PubMed ID: 32442502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA
    Jia N; Jones R; Yang G; Ouerfelli O; Patel DJ
    Mol Cell; 2019 Sep; 75(5):944-956.e6. PubMed ID: 31326273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system.
    Zhang D; Du L; Gao H; Yuan C; Lin Z
    Nucleic Acids Res; 2024 Aug; 52(14):8419-8430. PubMed ID: 38967023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System.
    Liu TY; Iavarone AT; Doudna JA
    PLoS One; 2017; 12(1):e0170552. PubMed ID: 28114398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral type III CRISPR signalling via conjugation of ATP and SAM.
    Chi H; Hoikkala V; Grüschow S; Graham S; Shirran S; White MF
    Nature; 2023 Oct; 622(7984):826-833. PubMed ID: 37853119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of cyclic tetra-oligoadenylate processing by small standalone CRISPR-Cas ring nucleases.
    Molina R; Garcia-Martin R; López-Méndez B; Jensen ALG; Ciges-Tomas JR; Marchena-Hurtado J; Stella S; Montoya G
    Nucleic Acids Res; 2022 Oct; 50(19):11199-11213. PubMed ID: 36271789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and biochemical analysis of nuclease domain of clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 3 (Cas3).
    Mulepati S; Bailey S
    J Biol Chem; 2011 Sep; 286(36):31896-903. PubMed ID: 21775431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of Csx1-cOA
    Molina R; Stella S; Feng M; Sofos N; Jauniskis V; Pozdnyakova I; López-Méndez B; She Q; Montoya G
    Nat Commun; 2019 Sep; 10(1):4302. PubMed ID: 31541109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6.
    Niewoehner O; Jinek M
    RNA; 2016 Mar; 22(3):318-29. PubMed ID: 26763118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type III CRISPR complexes from Thermus thermophilus.
    Szychowska M; Siwek W; Pawolski D; Kazrani AA; Pyrc K; Bochtler M
    Acta Biochim Pol; 2016; 63(2):377-86. PubMed ID: 27299480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Membrane-Associated DHH-DHHA1 Nuclease Degrades Type III CRISPR Second Messenger.
    Zhao R; Yang Y; Zheng F; Zeng Z; Feng W; Jin X; Wang J; Yang K; Liang YX; She Q; Han W
    Cell Rep; 2020 Sep; 32(11):108133. PubMed ID: 32937129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular architectures and mechanisms of Class 2 CRISPR-associated nucleases.
    Garcia-Doval C; Jinek M
    Curr Opin Struct Biol; 2017 Dec; 47():157-166. PubMed ID: 29107822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
    Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
    J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.